Evidence map›Paper›PMID 35690692›Full record

ArticleBone marrow transplantation2022

Practice patterns in chronic graft-versus-host disease patient management and patient reported outcome measures across the EBMT allogeneic transplantation network.

Vladimir Perovic, Ivan Sabol, Magdalena Grce, Marit Inngjerdingen, Drazen Pulanic, Zinaida Peric, Christophe Peczynski, Emmanuelle Polge, Christian Koenecke, Anne Dickinson and 11 more

Abstract readLetter
PubMed Full text at PMC Publisher
In one paragraph

Article in Bone marrow transplantation, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors.

Vladimir Perovic *Institute for Microbiology and Immunology, Faculty of Medicine, University of Belgrade, Belgrade, Serbia.ORCID http://orcid.org/0000-0002-1994-1738
Ivan Sabol *Division of Molecular Medicine, Ruđer Bošković Institute, Zagreb, Croatia.ORCID http://orcid.org/0000-0002-5753-8528
Magdalena GrceDivision of Molecular Medicine, Ruđer Bošković Institute, Zagreb, Croatia.ORCID http://orcid.org/0000-0001-6178-8418
Marit InngjerdingenDepartment of Pharmacology, Institute of Clinical Medicine, University of Oslo and Oslo University Hospital, Oslo, Norway.
Drazen PulanicDivision of Hematology, Department of Internal Medicine, University Hospital Center Zagreb, Zagreb, Croatia.
Zinaida PericDivision of Hematology, Department of Internal Medicine, University Hospital Center Zagreb, Zagreb, Croatia.ORCID http://orcid.org/0000-0001-9458-8025
Christophe PeczynskiClinical Sorbonne University Hematology and Cellular Therapy, Saint Antoine Hospital, INSERM UMR 938, Sorbonne University, Paris, France.ORCID http://orcid.org/0000-0002-3829-0088
Emmanuelle PolgeClinical Sorbonne University Hematology and Cellular Therapy, Saint Antoine Hospital, INSERM UMR 938, Sorbonne University, Paris, France.
Christian KoeneckeDepartment of Hematology, Hemostasis, Oncology and Stem Cell Transplantation, Hannover Medical School, Hannover, Germany.ORCID http://orcid.org/0000-0001-7025-1735
Anne DickinsonTranslational and Clinical Research Institute, Faculty of Medical Sciences, Newcastle University, Newcastle upon Tyne, United Kingdom.
Hildegard GreinixDivision of Hematology, Department of Internal Medicine, Medical University of Graz, Graz, Austria.
Grzegorz BasakDepartment of Hematology, Oncology and Internal Medicine, Medical University of Warsaw, Warsaw, Poland.
Olaf PenackCharité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Department of Department of Hematology, Oncology and Tumorimmunology, Berlin, Germany.ORCID http://orcid.org/0000-0003-4876-802X
Angela ScherwathDepartment of Stem Cell Transplantation, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
Anna BarataHealth Outcomes and Behavior Program, Moffitt Cancer Center, Tampa, FL, USA.ORCID http://orcid.org/0000-0003-0297-5920
Attilio OlivieriHematology Department and Stem Cell Transplant Unit, Università Politecnica delle Marche Università Politecnica delle Marche, Ancona, Italy.
Anita LawitschkaStem Cell Transplantation (SCT)-Outpatient and Aftercare Clinic, St. Anna Children's Hospital, Medical University Vienna, Vienna, Austria.ORCID http://orcid.org/0000-0002-4843-4735
Patrycja Mensah-GlanowskaJagiellonian University Medical College / University Hospital, Krakow, Poland.ORCID http://orcid.org/0000-0002-9850-2206
Hajnalka AndrikovicsLaboratory of Molecular Genetics, Central Hospital of Southern Pest, National Institute of Hematology and Infectious Diseases, Budapest, Hungary.
Helene Schoemans *Department of Public Health, University Hospitals of Leuven and KU Leuven, Leuven, Belgium.ORCID http://orcid.org/0000-0002-7568-8239
Daniel Wolff *Department of Internal Medicine III, Faculty of Medicine, University Hospital Regensburg, Regensburg, Germany. Daniel.Wolff@klinik.uni-regensburg.de.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Graft vs Host DiseaseHematopoietic Stem Cell TransplantationHumansPatient Reported Outcome MeasuresTransplantation ConditioningTransplantation, Homologous

Identifiers

PMID35690692
PMCPMC9439950

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.